教員業績データベース
English >>
TOPページ
>
中央診療施設
>
肝疾患センター
< 前年度
2015年度
2016年度
2017年度
次年度 >
肝疾患センター
Center for Liver Diseases
■
学術論文
原著
1.
Nishiguchi Shuhei
,Urano Yasuhisa,Suzaki Keiko,Taniguchi Atsushi,Scherer Joseph,Berger Kristi L, Quinson Anne-Marie,Stern Jerry O,Omata Masao.Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection.Hepatology Research 2017;47(3):E142-E151.
2.
Nishikawa Hisorki, Takata Ryo, Enomoto Hirayuki, Kazunori Yoh, Kishino Kyohei, Shimono Yoshihiro, Iwata Yoshinori, Hasegawa Kunihiro, Nakano Chikage, Nishimura Takashi, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Ishii Akio, Iijima Hiroko, Nishiguchi Shuhei.
.Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-po
sitive Mac-2-binding protein in chronic hepatitis C.Hepatology Research 2017;47(3):E74-E84.
3.
Matsumoto Akihiro, Imaizumi Masayasu, Tanaka Yasuhito,
Nishiguchi Shuhei
, Yatsuhashi Hiroshi,Ishida Takehiko, Moriyama Kazushige, Aoyagi Katsumi,Tanaka Eiji.Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.Journal of gastroenterology 2017;52(3):376-384
4.
Matsumoto Akihiro,
Nishiguchi Shuhei
, Enomoto Hirayuki, Kang Jong-Hon, Tanaka Yasuhito, Shinkai Noboru,Kurosaki Masayuki Enomoto Masaru, Kanda Tatsuo, Yokosuka Osamu, Yatsuhashi Hiroshi, Nagaoka Shinya, Okuse Chiaki, Kagawa Tatehiro, Mine Tetsuya, Takaguchi Koichi , Saito Satoru, Hino Keisuke, Ikeda Fusao, Sakisaka Shotaro, Morihara Daisuke, Miyase Shiho
Tsuge Masataka, Chayama Kazuaki, Hiramatsu Naoki, Suzuki Yoshiyuki, Murata Kazumoto, Tanaka Eiji.Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.Journal of Gastroenterology 2017;53(2):247-257
5.
Nishikawa Hiroki
, Nishijima Norihiro,
Enomoto Hirayuki
, Sakamoto Azusa, Nasu Akihiro,
Komekado Hideyuki,
Nishimura Takashi
, Kita Ryuichi , Kimura Toru,
Iijima Hiroko
,
Nishiguchi Shuhei
, Osaki Yukio.Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.jounal of cancer 2017;8(3):378-387
6.
Nishikawa Hiroki
, Nishijima Norihiro,
Enomoto Hirayuki
, Sakamoto Azusa , Nasu Akihiro,
Komekado Hideyuki,
Nishimura Takashi
, Kita Ryuichi, Kimura Toru ,
Iijima Hiroko
,
Nishiguchi Shuhei
, Osaki Yukio.Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir.Journal of Cancer 2017;8(2):152-161
7.
Aoki Tomoko,Iijima Hiroko,
Tada Toshifumi,Kumada Takashi,
Nishimura Takashi,Nakano Chikage,Kishino Kyohei,Shimono Yoshihiro,Yoh Kazunori,Takata Ryo,Ishii Akio,Takashima tomoyuki,Sakai Yoshiyuki,Aizawa Nobuhiro,Nishikawa Hiroki,Ikeda Naoto,Iwata Yoshinori,Enomoto Hirayuki,Hirota Seiichi,Fujimoto Jiro,Nishiguchi Shuhei
.Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases.Journal of Gastroenterology 2017;52(1):104-112
8.
Nishikawa Hiroki ,Enomoto Hirayuki, Iwata Yoshinori,Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Ishii Akio, Nishimura Takashi, Yoh Kazunori, Aizawa Nobuhiro,Sakai Yoshiyuki,Ikeda Naoto,Takashima, Tomoyuki, Iijima Hiroko, Nishiguchi Shuhei
.Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.Medicine (Baltimore) 2017;96(3):e5800
9.
Enomoto Hirayuki,Aizawa Nobuhiro
,Nakamura Hideji
,Sakai Yoshiyuki, Iwata Yoshinori, Tanaka Hironori, Ikeda Naoto, Aoki Tomoko, Yuri Yukihisa, Yoh Kazunori, Hasahimoto Kenji, Ishii Aakio, Takashima Tomoyuki, Iwata Kazunari, Saito Masaki, Imanishi Hiroyasu, Iijima Hiroko, Nishiguchi Shuhei.
.An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients.Gastroenterol Res Pract 2016;2016:7090351
10.
Yoh Kazunori, Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Nishimura Takashi, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Ishii Aakio, Iijima Hiroko, Matsunaga Hisato, Nakamura Hideji, Nishiguchi Sshuhei.
.Comparison of sleep disorders in chronic hepatitis C patients treated with interferon-based therapy and direct acting antivirals using actigraphy.Hepatology Research 2016;46(13):1358-1366
11.
Takashima Tomoyuki, Enomoto Hirayuki, Iwata Yoshinori, Nishikawa Hiroki, Yoh Kazunori, Hasegawa Kunihiro, Nakano Chikage, Yuri Yukihisa, Ishii Noriko, Miyamoto Yuho, Takata Ryo, Nishimura Takashi, Ishii Akio, Sakai Yoshiyuki, Aizawa Nobuhiro, Ikeda Naoto, Iijima Hiroko, Nishiguchi Sshuhei.
.Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients.Journal of Clinical Medicine Research 2016;8(12):854-858
12.
Sakai Yoshiyuki, Nishikawa Hiroki, Enomoto Hirayuki, Yoh Kazunori, Iwata Yoshinori, Hasegawa Kunihiro, Nakano Chikage, Kishino Kyohei, Shimono Yoshihiro, Takata Ryo, Nishimura Takashi, Aizawa Nobuhiro, Ikeda Naoto, Takashima Tomoyuki, Ishii Akio, Iijima Hiroko, Nishiguchi Shuhei
.Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.Journal of Clinical Medicine Research 2016;8(12):863-869
13.
Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Nishimura Takashi, Yoh Kazunori, Ishii Akio, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Iijima Hiroko, Nishiguchi Shuhei.
.Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.Journal of viral hepatitis 2016;23(12):977-984
14.
Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Yoh Kazunori, Nishimura Takashi, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Ishii Akio, Iijima Hiroko, Nakamura Hideji, Nishiguchi Shuhei.
.Clinical significance of serum wisteria floribunda agglutinin-positive Mac-2-binding protein level in non-alcoholic steatohepatitis.Hepatology Research. 2016;46(12):1194-1202
15.
Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage,Takata Ryo, Nishimura Takashi, Yoh Kazunori, Ishii Aakio, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Iijima Hiroko, Nishiguchi Shuhei.
.
.Clinical implication of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level on hepatitis B e-antigen loss or seroconversion in hepatitis B e-antigen positive patients.Hepatology Research 2016;46(11):1065-1073
16.
Mizokami Masashi, Dvory-Sobol H, Izumi Namiki,
Nishiguchi Shuhei
, Doehle B, Svarovskaia ES, De-Oertel S, Knox S, Brainard DM, Miller MD, Mo H, Sakamoto Naoya, Takehara Tetsuo, Omata Masao.Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies.Journal of Viral Hepatitis 2016;23(10):780-788
17.
Matsunami Kayoko , Nishida Nao, Kaneko Naoko, Ikeo Kazuho ,Toyo-oka Licht , Takeuchi Hiroshi,Matsuura Kentaro , Tamori, Akihiro, Nomura Hideyuki,Yoshiji Hitoshi ,Imamura Masatoshi , Masaki Naohiko, Hayakawa Tatsuro ,Ide Tatsuya ,Shimada Noritomo ,Ikeda Fusao , Hino Keisuke,
Nishiguchi Shuhei
,Okuse Chiaki ,Nojiri Shunsuke , Sawamoto Kazunobu , Tokunaga Katsushi, Joh Takashi , Tanaka Yasuhito.Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.PLOS ONE 2016;11(10):e0164418
18.
Okanoue Takeshi, Shima Toshihide, Hasebe Chitomi, Karino Yoshiyasu, Imazeki Fumio, Kumada Takashi, Minami Masahito, Imai Yasuharu, Yoshihara Harumasa, Mita Eiji, Morikawa Teruhisa,
Nishiguchi Shuhei
,Kawakami Yoshiiku, Nomura Hideyuki, Sakisaka Shotaro, Kurosaki Masayuki, Yatsuhashi Hiroshi, Oketani Makoto, Kohno Hiroshi, Masumoto Akihide, Ikeda Kenji, Kumada Hiromitsu.Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies.Hepatology Research 2016;46(10):992-1001
19.
Hasegawa Kunihiro, Takata Ryo, Nishikawa Hiroki, Enomoto Hirayuki, Ishii Aakio, Iwata Yoshinori, Miyamoto Yuho, Ishii Noriko, Yuri Yukihisa, Nakano Chikage, Nishimura Takashi, Yoh Kazunori, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Iijima Hiroko, Nishiguchi Shuhei.
.Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.International Journal of Molecular Sciences 2016;17(9):pii: E1500.
20.
Nishikawa Hiroki
, Nishijima Norihiro,
Enomoto Hirayuki
, Sakamoto Azusa, Nasu Akihiro, Komekado Hideyuki,
Nishimura Takashi
, Kita Ryuuichi, Kimura Toru,
Iijima Hiroko, Nishiguchi Shuhei
, Osaki Yukio.A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.Medicine (Baltimore). 2016;95(36):e4832
21.
Cai Xianbin
, Fang Chongye,
Hayashi Shuhei
, Hao Shumei,Zhao Mingming, Tsutsui Hiroko,
Nishiguchi Shuhei
,Sheng Jun.Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.Journal of Gastroenterology 2016;51(8):819-829
22.
Nishikawa Hiroki, Hasegawa Kunihiro ,Ishii Akio , Takata Ryo, Enomoto Hirayuki, Yoh Kazunori,Kishino Kyohei,Shimono Yoshihiro, Iwata Yoshinori, Nakano Chikage, Nishimura Takashi, Aizawa Nobuhiro,Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Iijima Hiroko , Nishiguchi Shuhei .
.A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.Medicine(Baltimore). 2016;95(35):e4679.-e4679.
23.
Nishikawa Hiroki, Enomoto Hirayuki, Yoh Kazunori, Iwata Yoshinori, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Kishino Kyohei, Shimono Yoshihiro, Sakai Yoshiyuki, Nishimura Takashi, Aizawa Nobuhiro, Ikeda Naoto, Takashima Tomoyuki, Ishii Akio, Iijima Hiroko, Nishiguchi Shuhei.
.Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.Medicine (Baltimore). 2016;95(24):e3920.
24.
Donald M Jensen, Tarik Asselah, Douglas Dieterich,Graham R Foster, Mark S Sulkowski, Stefan Zeuzem, Parvez Mantry, Eric M Yoshida, Christophe Moreno, Denis Ouzan, Mark Wright, Luis E Morano, Robert Buynak, Marc Bourlière, Tarek Hassanein,
Nishiguchi Shuhei
, Jia-Horng Kao, Omata Masao, Seung W Paik, David K Wong, Edward Tam, Kaita Kelly, S Victor Feinman, Jerry O Stern, Joseph Scherer, Anne-Marie Quinson, Florian Voss, John-Paul Gallivan, Wulf O Böcher, Peter Ferenc.Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1:pooled analysis of two phase 3 trials.Annals of hematology 2016;15(3):333-349
25.
Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Nishimura Takashi, Yoh Kazunori, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Iijima Hiroko, Nishiguchi Shuhei.
.Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level and high sensitivity C reactive protein concentration in autoimmune hepatitis.Hepatology Research 2016;46(7):613-621
26.
Taida Takashi, Arai Makoto, Kanda Tatsuo,Hige Shuhei,Ueno Yoshiyuki,Imazeki Fumio, Izumi Namiki, Tanaka Eiji, Shinkai Noboru, Yoshioka Kentaro,Nakamoto Yasunari,
Nishiguchi Shuhei
, Tsuge Masataka, Abe Masanori, Sata Michio, Yatsuhashi Hiroshi, Ido Akio, Kita Kazuhiko, Azemoto Ryousaku, Kitsukawa Yoshio, Goto Nobuaki, Yokosuka Osamu.The prognosis of hepatitis B inactive carriers in Japan:a multicenter prospective study.Journal of Gastroenterology 2016;52(1):113-122
27.
Enomoto Hirayuki, Nishikawa Hiroki, Ikeda Naoto, Aizawa Nobuhiro, Sakai Yoshiyuki, Yoh Kazunori, Takata Ryo, Hasegawa Kunihiro, Nakano Chikage, Nishimura Takashi, Ishii Akio, Takashima Tomoyuki, Iwata Yoshinori, Iijima Hiroko, Nishiguchi Shuhei.
.improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment.Hepatitis Monthly 2016;16(6):e35824.
28.
Nishikawa Hiroki, Enomoto Hirayuki, Iwata Yoshinori, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Nishimura Takashi, Kazunori Yoh, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Ishii Akio, Iijima Hiroko, Nishiguchi Shuhei.
.Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.Hepatol Res 2016;46(6):575-83
29.
Nishikawa Hiroki, Enomoto Hirayuki,Iwata Yoshinori, Hasegawa Kunihiro,Nakano Chikage,Takata Ryo,Nishimura Takashi,Yoh Kazunori,Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto,Takashima Tomoyuki, Ishii Akio,Iijima Hiroko, Nishiguchi Shuhei.
.Impact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis.Hepatology Research 2016;46(6):575-583
5件表示
全件表示(29件)
総説
1.
西川浩樹, 西口修平
.【見直す時期を迎えた肝硬変の治療】肝疾患とサルコペニア.消化器・肝臓内科 2017;1(3):330-336
2.
西川浩樹, 西口修平
.肝疾患におけるサルコペニアの判定基準(第1版) 作成に至る背景とプロセス.臨床栄養 2017;130(3):282-283
3.
西口修平
.ウイルス性肝炎の最新の治療.SRL宝函 2016;別冊(第13回SRL Update Forum講演集):26-32
4.
榎本平之, 西口修平
.【肝硬変を理解する-分子機構から実臨床に至るまで-】合併症の病態と治療 特発性細菌性腹膜炎.肝・胆・膵 2016;73(6):1224-1229
5.
榎本平之, 楊和典, 西川浩樹, 西口修平
.【新規技術が創り出す肝疾患診療のスペクタクル】病因の解析 肝炎における睡眠障害のアクティグラフでの評価.肝・胆・膵 2016;73(5):713-717
6.
Nishikawa Hirok
i, Shiraki Makoto, Hiramatsu Akira, Moriya Kyoji, Hino Keisuke,
Nishiguchi Shuhei
.Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.Hepatology Reaserch 2016;46(10):951-963
7.
西口修平.
.特集:肝硬変のマネージメント-その進歩と課題 肝硬変のマネージメント-最新の動向と今後の課題-.消化器の臨床 2016;19(3):187-191
8.
Nishikawa Hiroki, Nishiguchi Shuhei.
.Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.Internal medicine. 2016;55(8):855-856
5件表示
全件表示(8件)
■
その他
1.
坂井良行, 榎本平之, 西口修平
.慢性肝不全 その常識は正しいか? 肝性浮腫・腹水に対するアルブミン投与は有用である(保険診療の現状も含めて) (肝不全-その常識は正しいか?-).救急・集中治療 2016;28(5-6):404-408
2.
榎本平之,西口修平.
.内科:肝胆膵 B型肝炎ウィルスの再活性化【免疫力低下時にde novo肝炎が発生する恐れがある】.週間日本医事新報 2016;(4813):49
3.
榎本平之,西口修平.
.内科:肝胆膵 特発性細菌性腹膜炎【非代償性肝硬変例の約10~20%にみられる合併症で、早期の抗菌薬治療が鍵となる】.週間日本医事新報 2016;(4810):49
4.
岩田恵典,西口修平.
.臨床各科 差分解説内科:肝胆膵 慢性膵炎の診断【診断基準に早期慢性膵炎の概念が追加,早期介入による進展阻止に期待】.週肝 日本医事新報 2016;4820(2週):49-49
5.
西口修平.
.8大がんの進行ステージ手術実績トップ10はココだ! 肝がんのステージⅡにおける手術数1位.週刊ポスト. 2016;48(40):46
6.
西口修平.
.医なび肝がん 沈黙の臓器 早期検査を.夕刊 読売新聞 2016;2
7.
西口修平.
.ウィルス性肝炎 40歳からの、健康学第74回.ステーション12 2016;(338):90-91
8.
西口修平.
.必ず一度は検査受けて. 肝炎ウィルスを正しく知ろう.神戸新聞 2016;(42710):19
5件表示
全件表示(8件)
■
兼任
1.
西口 修平 (
内科学 肝・胆・膵科
)
2.
波多野 悦朗 (
外科学 肝・胆・膵外科
)